Viral Hepatitis

Overview

Journal Gut

Specialty Gastroenterology

Date 1991 Sep 1

PMID 1916470

Citations 3

Authors

J Y Lau

G J Alexander

A Alberti

Affiliations

Soon will be listed here.

Citing Articles

Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus.

Ndeboko B, Omouessi S, Ongali B, Mouinga-Ondeme A Pharmaceuticals (Basel). 2020; 13(12).

PMID: 33371278 PMC: 7766285. DOI: 10.3390/ph13120483.

Risks and benefits of interferon-alpha in the treatment of hepatitis.

Pardo M, Marriott E, Moliner M, Quiroga J, Carreno V Drug Saf. 1995; 13(5):304-16.

PMID: 8785018 DOI: 10.2165/00002018-199513050-00004.

Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.

Fang J, Wu P, Lai C, Lo C, Meager A, Lau J Dig Dis Sci. 1994; 39(9):2014-21.

PMID: 8082512 DOI: 10.1007/BF02088140.

References

Chisari F, Filippi P, McLachlan A, Milich D, Riggs M, Lee S . Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol. 1986; 60(3):880-7. PMC: 253312. DOI: 10.1128/JVI.60.3.880-887.1986. View

Seeger C, Ganem D, Varmus H . Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science. 1986; 232(4749):477-84. DOI: 10.1126/science.3961490. View

Choo Q, Weiner A, Overby L, Kuo G, Houghton M, Bradley D . Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull. 1990; 46(2):423-41. DOI: 10.1093/oxfordjournals.bmb.a072408. View

Reyes G, Purdy M, Kim J, Luk K, Young L, FRY K . Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990; 247(4948):1335-9. DOI: 10.1126/science.2107574. View

Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M . Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A. 1990; 87(3):983-7. PMC: 53394. DOI: 10.1073/pnas.87.3.983. View

Forbes A, Williams R . Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull. 1990; 46(2):303-18. DOI: 10.1093/oxfordjournals.bmb.a072400. View

Alberti A, Cavalletto D, Chemello L, Belussi F, Fattovich G, Pontisso P . Fine specificity of human antibody response to the PreS1 domain of hepatitis B virus. Hepatology. 1990; 12(2):199-203. DOI: 10.1002/hep.1840120204. View

Brunetto M, Stemler M, Bonino F, Schodel F, Oliveri F, Rizzetto M . A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol. 1990; 10(2):258-61. DOI: 10.1016/0168-8278(90)90062-v. View

Lee W, REED W, Osman C, VAHRMAN J, Zuckerman A, Eddleston A . Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut. 1977; 18(3):250-7. PMC: 1411397. DOI: 10.1136/gut.18.3.250. View

10.

Alberti A, Diana S, Sculard G, Eddleston A, Williams R . Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J. 1978; 2(6144):1056-8. PMC: 1608133. DOI: 10.1136/bmj.2.6144.1056. View

11.

Rizzetto M, Canese M, Arico S, Crivelli O, Trepo C, Bonino F . Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977; 18(12):997-1003. PMC: 1411847. DOI: 10.1136/gut.18.12.997. View

12.

El Sheikh N, Osman C, Cullens H, Eddleston A, Williams R . T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease. Clin Exp Immunol. 1978; 31(2):158-65. PMC: 1541222. View

13.

Jensen D, McFarlane I, Portmann B, Eddleston A, Williams R . Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978; 299(1):1-7. DOI: 10.1056/NEJM197807062990101. View

14.

Woolf I, El Sheikh N, Cullens H, Lee W, Eddleston A, Williams R . Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Br Med J. 1976; 2(6037):669-71. PMC: 1688339. DOI: 10.1136/bmj.2.6037.669. View

15.

Twu J, Schloemer R . Transcriptional trans-activating function of hepatitis B virus. J Virol. 1987; 61(11):3448-53. PMC: 255941. DOI: 10.1128/JVI.61.11.3448-3453.1987. View

16.

Seto E, Yen T, Peterlin B, Ou J . Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A. 1988; 85(21):8286-90. PMC: 282414. DOI: 10.1073/pnas.85.21.8286. View

17.

Sharmeen L, Kuo M, Taylor J . Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol. 1989; 63(3):1428-30. PMC: 247845. DOI: 10.1128/JVI.63.3.1428-1430.1989. View

18.

Twu J, ROBINSON W . Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A. 1989; 86(6):2046-50. PMC: 286844. DOI: 10.1073/pnas.86.6.2046. View

19.

Wu H, Lin Y, Lin F, Makino S, Chang M, Lai M . Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A. 1989; 86(6):1831-5. PMC: 286798. DOI: 10.1073/pnas.86.6.1831. View

20.

Wu H, Lai M . Reversible cleavage and ligation of hepatitis delta virus RNA. Science. 1989; 243(4891):652-4. DOI: 10.1126/science.2492677. View